Denmark is now a clear frontrunner in Europe, where countries and businesses are jostling for position for what that estimates soon will be a multibillion-dollar industry.  

An executive order to implement bulk cannabis exports from Denmark went into force Jan. 1, according to the Ministry of Health, putting Danish medical cannabis companies on a solid footing to compete across the European Union.


International companies have been plowing capital into Denmark’s nascent medical cannabis sector because of:

- The country’s technological advantage

- Strong plant breeding/genetics heritage 

- A supportive, stable government

- Among the cheapest power in Europe

- Easy access to the European Union market

Unlike in Germany – which will contract with private companies to produce a small amount of medical cannabis. Denmark has no limit on how much medical cannabis can be produced. Denmark also has among the cheapest power in Europe, which is one of the biggest input costs in medical cannabis cultivation.